Astec Lifesciences
ASTECNSE

Astec Lifesciences

₹544.45-13.40 (2.40%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
538.35
Today’s high
555.00
52 week low
513.40
52 week high
990.82
Open price
550.00
Previous close
557.85
Live volume
26,502
Lower circuit
446.30
Upper circuit
669.40

Fundamentals

Market Cap
₹1,242Cr
ROE
-27.52%
P/E Ratio(TTM)
-13.92
EPS(TTM)
-40.04
P/B Ratio
3.00
Dividend Yield
0.00%
Industry P/E
24.31
Book Value
185.77
Debt to Equity
0.89
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Astec LifeSciences is a key manufacturer of agrochemical ingredients and intermediate products, serving both Indian and global markets with a balanced sales mix. The company's core value is to create delight for its customers, placing them at the heart of everything it does to deliver great value. It has successfully established itself as a global leader in the production and supply of Triazole Fungicides, a vital crop protection chemical.;
MD/CEO
Mr. Ashok Hiremath
Founded in
--
NSE symbol
ASTEC
Industry

Shareholding Pattern

Mar '25
Jun '25
Jul '25
Sep '25
Dec '25
Promoters
71.97%
Retail And Others
24.82%
Mutual Funds
3.02%
Other Domestic Institutions
0.15%
Foreign Institutions
0.04%

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹233.65
+0.20 (0.09%)
L
    H
    4,535.0127.152.21
    ₹523.70
    +18.90 (3.74%)
    L
      H
      4,423.4142.249.66
      ₹942.80
      -0.25 (0.03%)
      L
        H
        4,253.3714.323.03
        ₹67.93
        -1.51 (2.17%)
        L
          H
          3,405.6117.491.33
          Livesquawk
          Astec Lifesciences' Q3 net loss narrows to ₹157M from ₹404M YoY. Q3 revenue rises to ₹1.25B, up from ₹939M YoY.
          Livesquawk
          Mugdha Amol Khare resigns as CFO of Astec Lifesciences.
          2026
          30
          Jan
          Quarterly Result
          Release date
          2025
          29
          Oct
          Quarterly Result
          Release date
          28
          Jul
          Quarterly Result
          Release date

          4
          Jul
          Rights Entitlement
          Ex date
          1:7
          Ratio

          1 rights eligible for every 7 existing shares held
          Ratio1:7
          Offer price₹890.00
          Ex date4 Jul ‘25
          Record date4 Jul ‘25
          Announcement date30 Jun ‘25

          30
          Jun
          Rights Entitlement
          Announced
          1:7
          Ratio

          1 rights eligible for every 7 existing shares held
          Ratio1:7
          Offer price₹890.00
          Ex date4 Jul ‘25
          Record date4 Jul ‘25
          Announcement date30 Jun ‘25
          Events calendar
          View upcoming events in other stocks